Keith McCarthy - Concepedia

Author

Keith McCarthy

Also Known As

K McCarthy, K P McCarthy, K. McCarthy, K. Mccarthy, K. P McCarthy, K. P. MCCARTHY, K. P. McCARTHY, K. P. McCarthy, K.P. McCARTHY, K.P. McCarthy

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Institut Gustave Roussy Royal Marsden Hospital Gloucestershire Hospitals NHS Foundation Trust Cheltenham General Hospital University of Utah

About

Keith McCarthy is an author at Institut Gustave Roussy specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	1.4K
2	Cell Biology	3	3	373
3	Health Sciences	1	1	20
4	Emergency Medicine	1	1	10
5	Health Law	1	1	10

Keith McCarthy

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients Catherine Patte, Anne Aupérin, Mary Gerrard, Blood	2006	427
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents Mitchell S. Cairo, Mary Gerrard, Richard Sposto, Blood	2006	359
A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Keith McCarthy, J P Sloane, Janusz H. Kabarowski, PubMed T-regulatory CellImmunologyPathologyMolecular GeneticsImmunotherapy	1992	259
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B‐cell non‐Hodgkin’s lymphoma: results of the FAB/LMB 96 international study* Mary Gerrard, Mitchell S. Cairo, Claire Weston, British Journal of Haematology Hematological MalignancyLymphoid NeoplasiaB NhlSurgical OncologyCopad Chemotherapy	2008	198
Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. Keith McCarthy, J P Sloane, Leanne M. Wiedemann Journal of Clinical Pathology Cell PathologyImmunologyDiagnosisPathologyOligomeric Primers	1990	190
Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study Mitchell S. Cairo, Richard Sposto, Mary Gerrard, Journal of Clinical Oncology	2012	181
Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study Marie‐Cécile Le Deley, Alfred Reiter, Denise Williams, Blood	2007	171
Prognostic Impact of Morphologic and Phenotypic Features of Childhood ALK-Positive Anaplastic Large-Cell Lymphoma: Results of the ALCL99 Study Laurence Lamant, Keith McCarthy, Emanuele S. G. d'Amore, Journal of Clinical Oncology	2011	163
Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer—A clinical and pathological evaluation Martin August Voss, Raji Ganesan, Linmarie Ludeman, Gynecologic Oncology Tumoral PathologyPathological EvaluationMedicineType 2Gynecology	2011	151
An improved method for detection of B-lymphoid clonality by polymerase chain reaction. Miriam Deane, Keith McCarthy, Leanne M. Wiedemann, PubMed	1991	140

Page 1